19/4 2010

Enact has supported AstraZeneca in arranging a stakeholder dialogue

Enact has once again supported AstraZeneca in organizing a stakeholder dialogue. The aim of the dialogue, which took place in January, was to get input from key stakeholders regarding AstraZeneca’s responsibility as a global biopharmaceutical company while increasing its presence in emerging markets. Twelve persons from Non-Governmental Organisations (NGOs), authorities as well as from the academic and political arena participated. Future challenges and opportunities were discussed and a number of concrete ideas and recommendations were put forward by the participants. AstraZeneca will take these ideas into consideration when planning for future activities.